The European MACUSTAR consortium is conducting a multi-country clinical study on age-related macular degeneration. The clinical study focuses on the intermediate stage of the disease, in which a person’s vision under low-light and low-contrast conditions is impaired. Throughout Europe, a total of 20 study centers will recruit and follow-up with 750 patients.